Molnupiravir has just been approved by Britain’s national medicines regulatory agency the first in the world to do so. Molnupiravir, made by Merck, a big pharma firm, and a Florida-based biotech called Ridgeback Biotherapeutics, is the first oral antiviral medicine available to treat covid-19. The approval marks another milestone in the world’s fight against covid-19. The interim results for last of a trial found that patients with a risk factor for covid-19 were 50% less likely to be hospitalised or die if the oral antibiotic was taken in the first five days after symptoms.DO you think that Molnupiravir is the Covid-19 “Cure”?
Previous Article
House of Commons RegulationsNext Article
Aviation free from fossil fuels.